microRNA are Central Players in Anti- and Profibrotic Gene Regulation during Liver Fibrosis.
about
Genetic and epigenetic regulation of intestinal fibrosisRole of Noncoding RNAs as Biomarker and Therapeutic Targets for Liver FibrosisTherapeutic potential of microRNA: a new target to treat intrahepatic portal hypertension?Reversibility and heritability of liver fibrosis: Implications for research and therapyRole of the microRNA-29 family in fibrotic skin diseases.The roles of microRNA families in hepatic fibrosis.MicroRNAs in liver diseaseMicroRNA function in the profibrogenic interplay upon chronic liver disease.Effects of β-sitosterol derived from Artemisia capillaris on the activated human hepatic stellate cells and dimethylnitrosamine-induced mouse liver fibrosisMiR-21 simultaneously regulates ERK1 signaling in HSC activation and hepatocyte EMT in hepatic fibrosisClass II HDAC inhibition hampers hepatic stellate cell activation by induction of microRNA-29Upregulation of miR21 and repression of Grhl3 by leptin mediates sinusoidal endothelial injury in experimental nonalcoholic steatohepatitis.Micro-RNA 21 inhibition of SMAD7 enhances fibrogenesis via leptin-mediated NADPH oxidase in experimental and human nonalcoholic steatohepatitisContribution of microRNA to pathological fibrosis in cardio-renal syndrome: impact of uremic toxinsPathophysiological role of microRNA-29 in pancreatic cancer stromamiR-122 negatively correlates with liver fibrosis as detected by histology and FibroScan.An HNF1α-regulated feedback circuit modulates hepatic fibrogenesis via the crosstalk between hepatocytes and hepatic stellate cells.miTALOS v2: Analyzing Tissue Specific microRNA FunctionActivation of the miR-34a/SIRT1/p53 Signaling Pathway Contributes to the Progress of Liver Fibrosis via Inducing Apoptosis in Hepatocytes but Not in HSCs.miR-21 Inhibition Reduces Liver Fibrosis and Prevents Tumor Development by Inducing Apoptosis of CD24+ Progenitor CellsSalvianolic acid B-induced microRNA-152 inhibits liver fibrosis by attenuating DNMT1-mediated Patched1 methylation.MicroRNAs as potential targets for progressive pulmonary fibrosisCirculating miR-21 and miR-29a as Markers of Disease Severity and Etiology in Cholestatic Pediatric Liver Disease.Inhibition of breast cancer cell motility with a non-cyclooxygenase inhibitory derivative of sulindac by suppressing TGFβ/miR-21 signaling.Apoptosis and necrosis in the liverThe persistence of low-grade inflammatory monocytes contributes to aggravated atherosclerosis.The autoregulatory feedback loop of microRNA-21/programmed cell death protein 4/activation protein-1 (MiR-21/PDCD4/AP-1) as a driving force for hepatic fibrosis development.Epigenetic regulation of connective tissue growth factor by MicroRNA-214 delivery in exosomes from mouse or human hepatic stellate cells.MicroRNA profile analysis in the liver fibrotic tissues of chronic hepatitis B patients.Immune regulation in chronic hepatitis C virus infection.Effect of TGF-β/smad signaling pathway blocking on expression profiles of miR-335, miR-150, miR-194, miR-27a, and miR-199a of hepatic stellate cells (HSCs)Reversal of liver cirrhosis: current evidence and expectations.miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes.Novel role of miR-29a in pancreatic cancer autophagy and its therapeutic potential.Circulating microRNAs as a marker for liver injury in human immunodeficiency virus patients.Curcumin up-regulates phosphatase and tensin homologue deleted on chromosome 10 through microRNA-mediated control of DNA methylation--a novel mechanism suppressing liver fibrosis.Computational identification of microRNAs and their targets in liver cirrhosis.miR-21 is involved in transforming growth factor β1-induced chemoresistance and invasion by targeting PTEN in breast cancer.Role of MicroRNAs in TGF-β Signaling Pathway-Mediated Pulmonary Fibrosis.The Role of miRNAs in the Pathophysiology of Liver Diseases and Toxicity.
P2860
Q26740553-6912E048-2279-464F-B0E8-03AAEB3C8786Q26774309-607584D5-9C48-403D-9609-4D1CA68C6D9AQ26829662-0634AB3B-E744-4681-986A-FBD9026B1DE5Q27026622-56646B9D-F0DE-4C48-A1C6-D7E79E137C81Q33742115-43F37B8E-7DF2-479C-8B5D-B008A5DC9125Q33868794-55FB6BE3-C3E2-4FD5-8C81-1F005C21C6CFQ33880442-DFB6F954-D664-4320-A6A1-9773C309B289Q33907481-799FE526-98E2-4E25-BFC8-0B167DB25EBDQ34320250-266C3B5E-944E-4D5D-8B48-B6A3B90C96D2Q34323121-33099E3A-57F6-4F02-A457-5F75F164E78AQ34576966-4A2DEF83-BAE6-4217-9678-C0A676F6CF10Q35057717-476183B4-09C6-4C38-BF9B-1A20D744C1D4Q35086412-BBEA8436-86F9-4F14-A01D-B74EA0C90C0EQ35588665-7853C637-67BA-4385-A597-84E4C49CB4D0Q35765000-B86AA59D-1802-42FC-9A45-4866A6CF90A7Q35819563-68034D75-3123-4059-816F-EF4F3B905664Q35925605-CE8E2D18-B086-4105-8D75-84695A2961ABQ35964688-724F9EE8-0064-4572-9367-C0702183FC11Q36069681-C499AFC5-E614-42EB-9E57-74F504F27EDBQ36154926-D41D4E68-57BC-4204-AAB9-384D2F7D747AQ36232847-77D96DA4-1364-4B4A-92F0-6931F923BE79Q36249425-8FB4923B-A0F2-4E89-A018-95447E28F8E1Q36735346-F3ADBDBC-01CA-4EEC-8963-9F3A7D170592Q36946688-30CCC6ED-D474-4926-B7A2-0B65C93E5D7CQ37403072-1943C81E-6DE8-4F26-BCB4-6D0A24CA7484Q37408646-700A619C-2C16-4FFE-987E-9EF65E0D55B0Q37415641-06985C82-B7A2-4002-A513-BCE8CDB9FDD6Q37619724-05281529-754B-464E-9DFE-08A1D2E034B1Q38437666-42A4AF67-9B06-4B05-A348-F510E42832C7Q38902559-51EBCA95-3A29-493D-A902-3FAB1E477949Q38963958-563D18CA-EBCA-4F1B-B9F6-1C34E2300E92Q38974002-4E667B87-A4FD-4508-95F6-7AAA58D1B116Q39215725-41FBBDD5-FA34-4141-86D0-959630E8A2C5Q39392030-1731B324-87E6-4AA5-8AE6-C47C14A65BAAQ42199832-B96D329E-CAE9-4124-A7D2-794E53319FB0Q46181877-568F02E7-5571-4562-BF71-FD3E86A0EB93Q47099635-19202F04-A8E0-4E1B-A41C-1B46FD5E2365Q47140406-4B75802E-F82E-42B7-B323-C58290E4A895Q47382571-46157145-0901-4ECA-9086-90FC1749396EQ47553075-4CD1BD09-5B8D-4BEF-8059-9E25EE4B016C
P2860
microRNA are Central Players in Anti- and Profibrotic Gene Regulation during Liver Fibrosis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
microRNA are Central Players i ...... ulation during Liver Fibrosis.
@en
type
label
microRNA are Central Players i ...... ulation during Liver Fibrosis.
@en
prefLabel
microRNA are Central Players i ...... ulation during Liver Fibrosis.
@en
P2093
P2860
P356
P1476
microRNA are Central Players i ...... ulation during Liver Fibrosis.
@en
P2093
Andrea Noetel
Margarete Odenthal
Monika Kwiecinski
Natalia Elfimova
P2860
P356
10.3389/FPHYS.2012.00049
P577
2012-03-19T00:00:00Z